2020-03-01ãã1ã¶æéã®è¨äºä¸è¦§
ãã¾ãæ¯æ¥COVID-19ã®è©±ã°ããã«ãªã£ã¦ãâ¦â¦ã¨ããé æ ®ããããå é±éææ¥ã«è¦³ã«è¡ã£ãæ ç»ãä¸å³¶ç±ç´å¤« vs æ±å¤§å ¨å ±é 50å¹´ç®ã®çå®ãã®ææ³ãªã©æ¸ãã¤ã¤ãããã«ç´ãè¾¼ã¾ãã¦ããã®åä»ãªææçã¨ã¤ãããæ¥ã ã«ã¤ãã¦æ¸ããã¨æã£ã¦ããããããããæ°æ¥ã®â¦
COVID-19é¢é£ã19æ¥å¤ã«å°é家ä¼è°ã«ããè¨è ä¼è¦ããããé ä¿¡ããã¦ããã®ãè¦ãã ç¶æ³åæã»æè¨ã®ææ¸ãå ¬éããã¦ãããåºæ¬çãªå¯¾å¿æéã«ã¤ãã¦ã¯ãããã¾ã§ã«å ¬è¡¨ãããå°é家ä¼è°ã®è¦è§£ã§ç¤ºããã¦ãããã®ã¨ç¹ã«å¤åã¯ãªãããã«è¦ããã ç¾ç¶åæâ¦
ããã®ã¨ããã®é¨ãã§ãä»äºã¨å®¶åºãåãã®ã«ç²¾ãã£ã±ããä¼æ¥ã¯ä½èª¿ã®å復ã«è²»ããæ¥ã ãç¶ãã¦ããã®ã ããæ¨æ¥ã®åææ¥ã¯ã¡ãã£ã¨æ£æ©ã«åºãå æ°ãåºããæããã®é¨ããæ¼éãã«ã¯ã¿ããã«ãããã¦å¤§ç²ã®éªã«å¤ãã£ãã ãã®å¬ã¯ç¹ã«éªãè¦ããã¨ãå°ãªãâ¦
ï¼æãããããããããã¨ããéã«ãä¸çã¯æ°åã³ããã¦ã¤ã«ã¹ææçï¼COVID-19ï¼ä¸è²ã«æã¾ã£ã¦ãã¾ã£ãã æ£ç¢ºãªæ å ±ãç解ããä¸ã®ä¸ã®åãã«åããã¦ä»äºã家åºã®ä½å¢ãæ´ãã¦ããã®ã«ãããã£ã±ãã®æ¥ã ã ã£ãã ã¾ã è½ã¡çããããã§ã¯å ¨ç¶ãªããããªâ¦
ãã°ããåã«ãããã°ãæ¸ããã¨ã«ã¾ã¤ããã¨ã³ããªãç¶ããã¾ã«æ稿ããã¦ãããã¨ããã£ã¦ãæãããæè¦ã«ã¡ãã£ã¨ããããããããããã¬ã¼ã次ã ã«è¨åãããæåã®è¡°éã¨ãã¯ã¦ãªããã¯ãã¼ã¯ã®å¤å®¹ - ã·ãã¯ãã®å±ç± æã·ãã¯ããããã®ã¨ã³ããªã«ç«¯ãâ¦